U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492030) titled 'Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions' on March 10.
Brief Summary: The central venous-arterial carbon dioxide tension difference is used daily in intensive care to establish peripheral tissue hypoperfusion, mainly mediated by a low cardiac index.
The partial pressures of gases (oxygen, carbon dioxide) increase in the blood of patients breathing 100% oxygen in hyperbaric conditions.
Thus, the validity of this biomarker in situations of acute circulatory failure during a hyperbaric oxygen therapy session has not been established.
The objective of the study is therefore to ...